Skip to main content
SpringerLink
Log in

Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the usefulness of osteopontin (OPN) expression level in plasma and tumor tissues of patients with laryngeal and hypopharyngeal squamous-cell carcinoma for predicting metastasis and survival of this tumor. The OPN expression in tumor tissues was detected by immunohistochemical staining in a tissue microarray of laryngeal and hypopharyngeal carcinomas, and the OPN level in plasma was measured by ELISA. The expression levels of OPN in plasma and tumor tissues were associated with clinicopathological features and survival of laryngeal and hypopharyngeal carcinomas. Results showed that the OPN expression quantitation either in tissues or plasma was significantly correlated with differentiation and lymphatic metastasis of the laryngeal and hypopharyngeal carcinoma. Elevated OPN level of plasma and tissues was significantly associated with poor survival. In conclusion, elevated OPN level in plasma and tumor tissues was significantly associated with metastasis and survival of laryngeal and hypopharyngeal carcinomas. Elevated OPN level in plasma and tumor tissues may become a useful indicator of prognosis for laryngeal and hypopharyngeal cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wai PY, Kuo PC. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev. 2008;27:103–18.

    Article  PubMed  CAS  Google Scholar 

  2. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin. Science. 1996;271:509–12.

    Article  PubMed  CAS  Google Scholar 

  3. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T. CD44 variants but not CD44S cooperated with betal-containing integrins to permit cell bind to osteopontin indcpend of arginine-glycine-aspartic acid, there by stimulating cell motility and chemotaxis. Cancer Res. 1999;59(1):219–26.

    PubMed  CAS  Google Scholar 

  4. EI Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 2006;17:463–74.

    Article  Google Scholar 

  5. Jweber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta. 2001;1552(2):61–85.

    Google Scholar 

  6. Crosby AH, Edwards SJ, Murray JC, Dixon MJ. Genomic organization of the human osteopontin gene:exclusion of the locus from a causative role in the pathogenesis of dentinogenesis impefecta typeII. Genomics. 1995;27(1):155–60.

    Article  PubMed  CAS  Google Scholar 

  7. Meerovitch K, Bergeron F, Leblond L, Grouix B, Poirier C, Bubenik M, Chan L, Gourdeau H, Bowlin T, Attardo G. A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vasc Pharmacol. 2003;40(2):77–89.

    Article  CAS  Google Scholar 

  8. Crawford HC, Matrisian LM, Liaw L. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res. 1998;58:5206–15.

    PubMed  CAS  Google Scholar 

  9. Gillespie MT, Thomas RJ, Pu ZY, Zhou H, Martin TJ, Findlay DM. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers. Int J Cancer. 1997;73:812–5.

    Article  PubMed  CAS  Google Scholar 

  10. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Osteopontin as a potential diagnostic biomarker for ovarian cancer. J Am Med Assoc. 2002;287:1671–9.

    Article  CAS  Google Scholar 

  11. Coppola D, Szabo M, Boulware D. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res. 2004;10:184–90.

    Article  PubMed  CAS  Google Scholar 

  12. Shimada Y, Watanabe G, Kawamura J, Soma T, Okabe M, Ito T, Inoue H, Kondo M, Mori Y, Tanaka E, Imamura M. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers. Oncology. 2005;68:285–92.

    Article  PubMed  CAS  Google Scholar 

  13. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res. 2001;7:4060–6.

    PubMed  CAS  Google Scholar 

  14. Hotte SJ, Winquist EW, Stitt L, Wilson SM, Chambers AF. Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer. 2002;95(3):506–12.

    Article  PubMed  CAS  Google Scholar 

  15. Lu JG, Sun YN, Wang C, de Jin J, Liu M. Role of the alpha v-integrin subunit in cell proliferation, apoptosis and tumor metastasis of laryngeal and hypopharyngeal squamous cell carcinomas: a clinical and in vitro investigation. Eur Arch Otorhinolaryngol. 2009;266:89–96.

    Article  PubMed  Google Scholar 

  16. Celetti A, Testa D, Staibano S, Merolla F, Guarino V, Castellone MD, Iovine R, Mansueto G, Somma P, De Rosa G, Galli V, Melillo RM, Santoro M. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Clin Cancer Res. 2005;15:8019–27.

    Article  Google Scholar 

  17. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell. 2004;5:311–6.

    Article  PubMed  CAS  Google Scholar 

  18. Liu M, Lawson G, Delos M, Jamart J, Remacle M. Expression of E-Cadherin adhesion molecule in vocal cord carcinoma. Eur Arch Otorhinolaryngol. 1997;254:417–21.

    Article  PubMed  CAS  Google Scholar 

  19. Liu M, Lawson G, Delos M, Jamart J, Chatelain B, Remacle M, Marbaix E. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol. 2003;260:28–34.

    PubMed  Google Scholar 

  20. Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer. 2004;90:1877–81.

    Article  PubMed  CAS  Google Scholar 

  21. Zitzmann S, Ehemann V, Schwab M. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res. 2002;62(18):5139–43.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

I would like to express my gratefulness to my chief adviser, Prof. JG LU, for his patience, encouragement and professional guidance throughout the whole project. Besides, I would like to thank all my friends for their help and advice. Finally, I would like to have sincere thanks to all volunteers who took part in the investigation. Without their participation, this project might not have been made possible and successful.

Author information

Authors and Affiliations

  1. Department of Otolaryngology/Head and Neck Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China

    Yong Li, Liang Li, Jing Ting Wang, Xuan Kan & Jian Guang Lu

Authors
  1. Yong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing Ting Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xuan Kan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jian Guang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian Guang Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Li, L., Wang, J.T. et al. Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis. Med Oncol 29, 1429–1434 (2012). https://doi.org/10.1007/s12032-011-0012-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-0012-z

Keywords

Search

Navigation